Alan L Mueller
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2014First federal award
$2.9MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $2.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 23, 2019 | NIH | SBIR Phase I Stabilization of the Alveolar-Capillary Barrier with ARF6 Inhibitor as a Treatment for Severe Influenza | $268K | NAVIGEN, INC. |
| Aug 3, 2018 | NIH | SBIR Phase I ARF6 Inhibitor as Adjunctive Therapy for Treatment of SA Bacteremia | $300K | NAVIGEN, INC. |
| May 24, 2018 | NIH | SBIR Phase II ARF6 Inhibitors for Treatment of Acute Lung Injury | $817K | NAVIGEN, INC. |
| Apr 10, 2015 | NIH | SBIR Phase I Arf6 inhibitors for the treatment of uveal melanoma | $299K | NAVIGEN, INC. |
| Mar 3, 2015 | NIH | SBIR Phase I Treating Acute Lung Injury via Cytokine Signaling Blockade | $225K | NAVIGEN, INC. |
| Nov 25, 2014 | NIH | SBIR Phase II Therapeutic D-peptide Inhibitor of HIV Entry | $1.0M | NAVIGEN, INC. |
Peer ranks
Federal funding#649
Awards as PI#315
Patents#273
Companies
- NAVIGEN, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.